Literature DB >> 8834065

Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways.

M Boirivant1, I Fuss, C Fiocchi, J S Klein, S A Strong, W Strober.   

Abstract

Human lamina propria (LP) T cells exhibit a reduced proliferative capacity in response to antigen-specific stimulation. To investigate the functional state of such hypoproliferative T cells, we determined the capacity of LP T cells to produce lymphokines when stimulated by monoclonal antibodies that crosslink either the TCR/CD3 complex or accessory pathway molecules (CD2,CD28). We found that TCR/CD3-mediated proliferative responses of LP T cells were greatly diminished when compared to peripheral blood (PB) T cells, but were largely restored when cells were preincubated in IL-2. Despite their proliferative hyporesponsiveness, LP T cells (as compared to PB T cells) secreted equal amounts of IL-2 and increased amounts of IFN-gamma, IL-4 and IL-5; these increased cytokine responses were most evident when cells were stimulated via the accessory pathways. In further studies, purified CD4+ LP T cells were compared with purified CD4+/CD45RO+ PB T cells (i.e., the PB T cell subset they most resemble). LP T cells produced significantly more IFN-gamma and IL-5 but less IL-4 than their CD45RO+ PB counterparts. Overall, LP T cells are unresponsive T cells following stimulation via the TCR/CD3 pathway but nevertheless retain the capacity to produce increased levels of TH1 and TH2-type lymphokines following stimulation via the CD2/CD28 accessory pathway; thus, they are best classified as modified "anergic" T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834065

Source DB:  PubMed          Journal:  Proc Assoc Am Physicians        ISSN: 1081-650X


  10 in total

1.  T-cell populations in the pig intestinal lamina propria: memory cells with unusual phenotypic characteristics.

Authors:  K Haverson; M Bailey; C R Stokes
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.

Authors:  M Boirivant; R Pica; R DeMaria; R Testi; F Pallone; W Strober
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 3.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Human mucosal CD4+ T cells but not blood CD4+ T cells respond vigorously towards CD28 engagement.

Authors:  J Schröder-Braunstein; V Pavlov; T Giese; A Heidtmann; S Wentrup; F Lasitschka; J Winter; A Ulrich; A Engelke; M Al Saeedi; S Meuer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.

Authors:  Z Hel; J Nacsa; B Kelsall; W P Tsai; N Letvin; R W Parks; E Tryniszewska; L Picker; M G Lewis; Y Edghill-Smith; M Moniuszko; R Pal; L Stevceva; J D Altman; T M Allen; D Watkins; J V Torres; J A Berzofsky; I M Belyakov; W Strober; G Franchini
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis.

Authors:  M Boirivant; M Viora; L Giordani; A L Luzzati; A M Pronio; C Montesani; O Pugliese
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

7.  p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.

Authors:  Andreas Sturm; Jugoh Itoh; James W Jacobberger; Claudio Fiocchi
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

8.  Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.

Authors:  M Viora; G Di Genova; M G Quaranta; M Boirivant; B Camponeschi
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

9.  Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes.

Authors:  J Braunstein; F Autschbach; T Giese; F Lasitschka; A Heidtmann; B Sido; B Funke; C Reiser; A J Schröder; G Nebl; Y Samstag; S C Meuer
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

10.  Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®.

Authors:  Anne-Kristin Heninger; Sabine Wentrup; Mohammed Al-Saeedi; Serin Schiessling; Thomas Giese; Florian Wartha; Stefan Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2014-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.